Literature DB >> 6288542

Geographic distribution of HBsAg carriers in China.

R P Beasley, C C Lin, C S Chien, C J Chen, L Y Hwang.   

Abstract

We tested by radioimmunoassay the sera of 22,707 male Chinese government employees in Taiwan for HBsAg and found 15.2% to be positive. Almost all were confirmed as carriers by follow-up testing 1 year later. This paper presents HBsAg positivity rates of these men according to the province of China from which they originated, and compares the rates with published provincial mortality rates for primary hepatocellular carcinoma. Moderate variation in carrier rates between provinces was observed with high prevalence in men from provinces south of the Yangtze River. There was positive correlation between HBsAg prevalence and primary hepatocellular carcinoma incidence giving further support to the possibility of a causal relationship.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288542     DOI: 10.1002/hep.1840020507

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.

Authors:  Yu-Jing Zhang; Hui-Chen Wu; Hulya Yazici; Ming-Whei Yu; Po-Huang Lee; Regina M Santella
Journal:  World J Hepatol       Date:  2012-05-27

Review 2.  Viral hepatitis B: clinical and epidemiological characteristics.

Authors:  Gregory S Burns; Alexander J Thompson
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-30       Impact factor: 6.915

3.  Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China.

Authors:  Yao He; Pingping Xu; Yujun Chen; Rongping Yang; Baili Chen; Zhirong Zeng; Minhu Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside.

Authors:  M J Fowler; J Monjardino; I V Weller; A S Lok; H C Thomas
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

Review 5.  Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.

Authors:  Masahiro Tanaka; Francisco Katayama; Hideaki Kato; Hideo Tanaka; Jianbing Wang; You Lin Qiao; Manami Inoue
Journal:  J Epidemiol       Date:  2011-10-22       Impact factor: 3.211

6.  Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection.

Authors:  Ana Caroline Ferreira da Silva; Marlone Cunha-Silva; Tiago Sevá-Pereira; Daniel F Mazo
Journal:  Viruses       Date:  2022-09-05       Impact factor: 5.818

7.  Ethyl pyruvate pretreatment attenuates concanavalin a-induced autoimmune hepatitis in mice.

Authors:  Miao Shen; Jie Lu; Ping Cheng; Chunlei Lin; Weiqi Dai; Fan Wang; Chengfen Wang; Yan Zhang; Kan Chen; Ling Xu; Yinqun Zhou; Chuanyong Guo
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 8.  RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies.

Authors:  Christine I Wooddell; Adam J Gehring; Man-Fung Yuen; Bruce D Given
Journal:  Viruses       Date:  2021-03-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.